how overweight for semaglutide GLP-1 Weight Loss Clinic Serving Miami, FL Semaglutide and Weight Loss: What

Safe travels

Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed for weight management in adults with obesity or overweight with comorbidities Common gastrointestinal side effects including nausea (affecting approximately 43% of patients) may indirectly reduce interest in sexual activity Significant weight loss can temporarily affect hormone levels, energy, and body image, though obesity itself is associated with higher rates of sexual dysfunction Weight loss may increase fertility

It also helps in reducing those lipid levels, which is a big thumbs up for reducing the risk of heart attack, stroke, or death (reference)

While the journey toward widespread adoption of semaglutide for non-diabetic CKD continues, these early results are promising

It works by mimicking the action of GLP-1, a naturally occurring hormone that regulates blood sugar levels and appetite